STEPHANIE SELLS: Open Payments
NPI 1770908998 · HALLS, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,240 in 61 payments from 12 companies in 2025. Trend: 2023 $704 · 2024 $696 · 2025 $1,240
Food & beverage: $1,240
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $229 |
| Novo Nordisk Inc | 13 | $228 |
| AstraZeneca Pharmaceuticals LP | 5 | $197 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $171 |
| Otsuka America Pharmaceutical, Inc. | 10 | $158 |
| Lundbeck LLC | 3 | $90 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $55 |
| Amgen Inc. | 3 | $47 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $20 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $18 |
Products named: REXULTI, VRAYLAR, Ozempic, CAPLYTA, FARXIGA, TRINTELLIX, OTEZLA, AIRSUPRA.
Industry payments across TN — which companies pay providers there.
